Recent News for ONCS - OncoSec Medical Incorporated

Date Title
Sep 20 OncoSec to Present at the Ladenburg Thalmann 2019 Healthcare Conference
Sep 6 OncoSec to Present at the 21st Annual H.C. Wainwright Global Investment Conference
Aug 24 Mixed shelf roundup
Aug 12 Morgan Stanley sees 58% upside in Genmab in premarket analyst action
Jul 29 OncoSec Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Application with Claims Covering Cytokine-Based Intratumoral Immunotherapies
Jul 16 OncoSec Issues Letter to Shareholders
Jul 10 OncoSec Medical and Trinity Biotech among healthcare gainers; Amneal Pharmaceuticals leads the losers
Jul 10 The Daily Biotech Pulse: Jazz Buys Tumor Drug Program, Sanofi's BLA For Multiple Myeloma Drug Accepted, Positive Results For ViiV
Jul 5 The Daily Biotech Pulse: FDA Approves Karyopharm's Blood Cancer Treatment, Grifols' Immunodeficiency Drug; ESMO, ISTH Conferences In The Spotlight
Jul 4 OncoSec's Licensing Of CAR-T Tech For Solid Tumors Opens Up A New Door For The Future
Jun 27 NVAX, AAOI among premarket gainers
Jun 27 OncoSec Receives Exclusive Licensing Rights from Dana-Farber Cancer Institute to CAR T-Cell Therapies for the Treatment of Solid Tumor Cancers
Jun 17 OncoSec Announces Research Collaboration with Roswell Park Comprehensive Cancer Center Using Cutting-Edge Intravital Microscopy (IVM), TAVO-PLUS and APOLLO™ Electroporation Generator
Jun 13 OncoSec to Present Immunological Data at World Pharma Week 2019
Jun 7 featured highlights include: HP, Party City, AbbVie, OncoSec Medical and Pulmatrix
Jun 6 CIEN, SFIX, HOME and CLDR among midday movers
Jun 6 Bet on 5 Top Stocks With Rising P/E
May 29 OncoSec to commercialize TAVO in Australia/New Zealand
May 29 OncoSec Announces Collaboration For TAVO™ In Australia With Emerge Health
May 28 Biocept and OncoSec Medical among healthcare gainers; Teva Pharmaceutical and Zynerba Pharmaceuticals among losers
May 28 OncoSec Medical Incorporated Announces Closing of $11.0 Million Public Offering and Terminates ATM and Other Financing Facility
May 24 Secondary Offerings Put A Pause On May's Momentum
May 24 The Daily Biotech Pulse: FDA Nod For Novocure, Dynavax Restructures, Therapix Receives Nasdaq Notice
May 23 UCSF Doses First Patient in Triple Combination Clinical Trial of OncoSec's TAVO™, Epacadostat and KEYTRUDA® for the Treatment of Unresectable Squamous Cell Head and Neck Cancer
May 22 AVP, PSTG, SSL and SE among midday movers
Back to the Main ONCS Page...